Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Gastric Cancer
Published in: Gastric Cancer 4/2010

01-11-2010 | Original Article

Safety and efficacy of S-1 monotherapy in elderly patients with advanced gastric cancer

Authors: Takahiro Tsushima, Shuichi Hironaka, Narikazu Boku, Nozomu Machida, Kentaro Yamazaki, Hirofumi Yasui, Keisei Taku, Akira Fukutomi, Yusuke Onozawa

Published in: Gastric Cancer | Issue 4/2010

Login to get access
Metadata
Title
Safety and efficacy of S-1 monotherapy in elderly patients with advanced gastric cancer
Authors
Takahiro Tsushima
Shuichi Hironaka
Narikazu Boku
Nozomu Machida
Kentaro Yamazaki
Hirofumi Yasui
Keisei Taku
Akira Fukutomi
Yusuke Onozawa
Publication date
01-11-2010
Publisher
Springer Japan
Published in
Gastric Cancer / Issue 4/2010
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-010-0566-z

Other articles of this Issue 4/2010

Gastric Cancer 4/2010 Go to the issue

Review Article

Roles of inflammatory cytokines in the progression of gastric cancer: friends or foes?

Short communication

A case of small undifferentiated intramucosal gastric cancer with lymph node metastasis

Original Article

No associations of Toll-like receptor 2 (TLR2) -196 to -174del polymorphism with the risk of Helicobacter pylori seropositivity, gastric atrophy, and gastric cancer in Japanese

Case report

Lymph node metastasis from undifferentiated-type mucosal gastric cancer satisfying the expanded criteria for endoscopic resection based on routine histological examination

Original Article

Socioeconomic status and gastric cancer survival in Japan

Editorial

Endoscopic resection of undifferentiated-type gastric carcinoma: an extreme step to be restrained?
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits